In This Article:
Villers-lès-Nancy, 30 April 2025 - 8:00 AM (CET)
PRESS RELEASE
EXCLUSIVE NEGOTIATIONS INITIATED WITH A FRENCH SOFTWARE EDITOR TO ACQUIRE TWO SOFTWARE PUBLISHING BUSINESSES OPERATING IN THE PUBLIC HEALTH SECTOR
-
Project for a targeted acquisition in the public health sector:
-
Acquisition of Novaprove, publisher of the ResUrgences software,
-
Acquisition of the DIS business assets,
-
-
Strategic reinforcement of Equasens Group's Axigate Link division in this market segment
***
Equasens Group (Euronext Paris™ - Compartment B - FR 0012882389 -$EQS), today announced that through its subsidiary Axigate, publisher of the HOSPILINK electronic medical record (EMR) solution for hospitals, the Axigate Link Division has entered into exclusive negotiations with a French software solutions editor regarding the possibility of acquiring two businesses specialising in software solutions for the public healthcare sector.
Nature and scope of the proposed acquisition
This proposed acquisition covers two complementary businesses:
Firstly, ResUrgences (Novaprove), a web-based software platform specialising in the management of hospital emergency medical services featuring a new and innovative technological solution that optimises patient intake, pathway management and emergency care delivery processes.
Secondly, the comprehensive DIS (including FACDIS) suite of digital solutions for public healthcare establishments, covering accounting, billing, human resources and financial management that work seamlessly with the electronic patient record.
If this transaction is completed, these two activities would be integrated into the Axigate Link Division, a European expert in software and applications for health and medico-social establishments.
A strong strategic focus
This project is fully in line with Equasens' development strategy by seeking to reinforce its positioning and market share in the fast-growing public health software sector.
Through this acquisition, the Group also seeks to expand its portfolio of solutions by offering a more comprehensive, high value-added offering. The resulting technical and commercial synergies with the Axigate Link Division's existing solutions will be a major growth driver by optimising resources and accelerating innovation.
Finally, this potential acquisition would contribute to consolidating the Group's position as a driving force in the digital transformation of the healthcare system, by providing increasingly customised solutions adapted to the specific needs of healthcare establishments and their practitioners.